The end of a shortage of popular weight-loss drugs may mean many people lose access to them
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...
Lilly weight-loss drug copycats dealt blow as shortage ends
Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the U.S., ...
Business Insider24d
Weight-loss drugs are life-changing — and expensive. Here's one woman's solution.
which later won FDA approval for weight loss in 2023 under the brand name Zepbound. A similar version of this drug, called Mounjaro, has been available to people with type 2 diabetes since ...
US FDA to reconsider decision barring compounded versions of Lilly weight loss drug
The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...
CBS News29d
While brand-name weight loss drugs are in short supply, a market for alternatives thrives
Nearly a quarter of the websites that CBS News identified did not disclose the drugs they were advertising were compounded. There is no FDA-approved generic version of brand-name weight loss ...
Page Six10d
Celebrities on Ozempic: All the stars who’ve used weight-loss drugs
Ozempic is the newest craze to take ... the billionaire tweeted on Oct. 1, 2022, “Fasting” and “Wegovy.” Oprah Winfrey did not specify which weight-loss drug she uses.